Mowery & Schoenfeld Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.63K Hold
25
0.01% 268
2025
Q4
$6.04K Hold
25
0.01% 305
2025
Q3
$6.86K Hold
25
0.01% 253
2025
Q2
$6.47K Hold
25
0.01% 250
2025
Q1
$5.61K Sell
25
-3
-11% -$700 0.01% 317
2024
Q4
$6.4K Buy
+28
New +$6.74K 0.01% 274

Other funds holding RMD

Mowery & Schoenfeld Wealth Management's RMD Position: Q1 2026 in Review

Mowery & Schoenfeld Wealth Management held its ResMed (RMD) position steady in Q1 2026 at 25 shares worth $5.63K. The position accounts for 0.01% of the portfolio, ranked #268.

Mowery & Schoenfeld Wealth Management first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.86K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Mowery & Schoenfeld Wealth Management held 25 shares of ResMed worth $5.63K as of Q1 2026.
  • Mowery & Schoenfeld Wealth Management left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.01% of Mowery & Schoenfeld Wealth Management's portfolio in Q1 2026, its #268 holding.
  • Mowery & Schoenfeld Wealth Management first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Mowery & Schoenfeld Wealth Management's ResMed position peaked at $6.86K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.